Warby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) Price to free cash flow
As of 5 November 2026, Warby Parker Inc. (WRBY) trades at a price to free cash flow of 153×. Over the past ten years it has ranged from 0.0× (September 2023) to 241× (February 2024); the current reading is higher than 93% of that period. That is above the Medical Instruments & Supplies industry median of 23.5× and above the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 61.1× | (27.21%) |
| FY2024 | 84.0× | (64.86%) |
| FY2023 | 239× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 163× | (5.88%) |
| Jun 2026 | 173× | 158.65% |
| Mar 2026 | 66.9× | 9.39% |
| Dec 2025 | 61.1× | (31.89%) |
| 22 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| STVN Stevanato Group S.p.A. compare | n/m |
| PLSE Pulse Biosciences, Inc compare | n/m |
| KMTS Kestra Medical Technologies, Ltd. compare | n/m |
| XRAY DENTSPLY SIRONA Inc. compare | 21.1× |
| ICUI ICU Medical, Inc. compare | 21.2× |
| LMAT LeMaitre Vascular, Inc. compare | 28.3× |
| ATRC AtriCure, Inc. compare | 129× |
| WRBY Warby Parker Inc. | 153× |
| AZTA Azenta, Inc. compare | 172× |
| Medical Instruments & Supplies industry median | 23.5× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on WRBY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement